Navigation Links
ViroPharma Announces Positive CHMP Opinion for Cinryze® (C1 Inhibitor [Human]) in European Union
Date:3/18/2011

/p>

The most common adverse reactions observed have been upper respiratory infection, sinusitis, rash and headache. No drug-related serious adverse events (SAEs) have been observed in clinical trials.

Cinryze is for intravenous use only. Per the U.S. label, a dose of 1000 Units of Cinryze can be administered every 3 or 4 days for routine prophylaxis against angioedema attacks in HAE patients. Cinryze is administered at an injection rate of 1 mL per minute.

About Hereditary Angioedema (HAE)

HAE is a rare, severely debilitating, life-threatening genetic disorder caused by a deficiency of C1 inhibitor, a human plasma protein. This condition is the result of a defect in the gene controlling the synthesis of C1 inhibitor. C1 inhibitor maintains the natural regulation of the contact, complement, and fibrinolytic systems, that when left unregulated, can initiate or perpetuate an attack by consuming the already low levels of endogenous C1 inhibitor in HAE patients. Patients with C1 inhibitor deficiency experience recurrent, unpredictable, debilitating, and potentially life threatening attacks of inflammation affecting the larynx, abdomen, face, extremities and urogenital tract. Patients with HAE experience approximately 20 to 100 days of incapacitation per year. There are estimated to be at least 6,500 people with HAE in the United States and approximately similar demographics in the European Union.

For more information on HAE, visit the U.S. HAE Association's website at: www.haea.org or the HAEi (International Patient Organization for C1 Inhibitor Deficiencies) at www.haei.org.

About ViroPharma Incorporated

ViroPharma Incorporated is an international biopharmaceutical company committed to developing and commercializing innovative products for physician specialists to enable the support of patients with serious diseases for which there is
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. ViroPharma to Present at Three Upcoming Healthcare Conferences
2. ViroPharma to Present at the Natixis Bleichroeder Conference
3. ViroPharma To Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
4. ViroPharma to Release 2008 First Quarter Financial Results on April 30, 2008
5. ViroPharma Announces Discontinuation of HCV-796 Development
6. ViroPharma Announces Completion of Enrollment in Phase 3 Study of Maribavir in Stem Cell Transplant Patients
7. ViroPharma Incorporated Completes Acquisition of Lev Pharmaceuticals
8. ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema
9. ViroPharma Announces Discontinuation of Maribavir Phase 3 Study in Liver Transplant Patients
10. ViroPharma Submits Comments on Vancocin(R) Draft Bioequivalence Guidance
11. ViroPharma Incorporated Reports Third Quarter 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... , September 23, 2014 ... oncology biopharmaceutical company, today announces it has been ... Drug Discovery Award from the UK,s Wellcome Trust ... its proprietary, novel cancer target. The ... identify and fund especially promising, innovative new therapeutic ...
(Date:9/23/2014)... 23, 2014  As physicians seek information about ... channels to learn about new therapies or ask ... a new report by global sales and marketing ... communicating via a customized mix of digital media ... opportunity to engage with physicians. And, productive engagement ...
(Date:9/23/2014)... 2014   BioLife Solutions , Inc. (NASDAQ: ... of proprietary clinical grade hypothermic storage and ... shipping products for cells and tissues  ("BioLife" or ... Scientific Advisory Board.  The new members are Jason ... Dr. Acker is a Senior Development Scientist ...
Breaking Medicine Technology:BerGenBio Granted a Prestigious Wellcome Trust Seeding Drug Discovery Award 2BerGenBio Granted a Prestigious Wellcome Trust Seeding Drug Discovery Award 3As sales reps see doors close for in-person visits with physicians, digital doors open communication 2As sales reps see doors close for in-person visits with physicians, digital doors open communication 3As sales reps see doors close for in-person visits with physicians, digital doors open communication 4As sales reps see doors close for in-person visits with physicians, digital doors open communication 5BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 2BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 3BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 4BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 5BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 6BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 7
... Perceptive Informatics ® , a leading eClinical ... (NASDAQ: PRXL ), today announced that its ... highest among EDC solutions for overall satisfaction in ISR,s ... independent study conducted by Industry Standard Research (ISR).  The ...
... 2011 Next Generation Pharmaceutical Manufacturing Europe ... Barcelona, Spain and will provide leading executives with an ... The summit has elected more than 50 of ... industry. Speakers will include Bo Hilligsøe, VP Finished Goods ...
Cached Medicine Technology:Perceptive Informatics® DataLabs® EDC Solution Ranks Highest in Overall Satisfaction 2Perceptive Informatics® DataLabs® EDC Solution Ranks Highest in Overall Satisfaction 3Perceptive Informatics® DataLabs® EDC Solution Ranks Highest in Overall Satisfaction 4Perceptive Informatics® DataLabs® EDC Solution Ranks Highest in Overall Satisfaction 5The Next Generation Pharmaceutical Manufacturing Summit 2
(Date:9/23/2014)... 2014 The "area under the curve of oxygen ... approach to monitoring blood oxygen levels during procedures using ... & Analgesia . , The AUC Desat provides ... lowbut also on the depth, duration, and rate of ... Paul Niklewski, PhD, of University of Cincinnati and colleagues ...
(Date:9/23/2014)... the physical and mental health of girls and ... by researchers from the Institute for Reproductive Health ... effective strategies to change inequitable and harmful social ... Inequitable gender norms are not only related to ... as multiple sexual partners, smoking and alcohol abuse ...
(Date:9/23/2014)... (PRWEB) September 23, 2014 The ... is now offering complimentary oral sedation with treatment for ... of Americans suffer from dental anxiety or dental phobia. ... patients; they can also keep patients from seeking desperately ... phobia in Westlake Village and surrounding areas now have ...
(Date:9/23/2014)... On September 23, 2014, My Positive Perspective founder Jason Deierlein ... the founder of Traveler of Charleston magazine and answered some ... At the start of the interview, Deierlein asked Simmons, “How ... replied by saying, “I had worked for the yellow pages ... and decided to start my own magazine thinking I could ...
(Date:9/23/2014)... The U.S. Pharmacopeial Convention (USP) has submitted ... (WHO) regarding the assignment of Biological Qualifiers (BQ) to ... Expert Group of the Programme of International Nonproprietary Names ... naming of all biologicals that is consistent with existing, ... these drugs. , Hence, USP supports the concept ...
Breaking Medicine News(10 mins):Health News:New measure provides more data on oxygen levels during sedation 2Health News:Safe passages into adulthood: Preventing gender-based violence and its consequences 2Health News:Safe passages into adulthood: Preventing gender-based violence and its consequences 3Health News:The Sedation Dental Office is Now Offering Complimentary Oral Sedation with Treatment for New Patients 2Health News:The Sedation Dental Office is Now Offering Complimentary Oral Sedation with Treatment for New Patients 3Health News:My Positive Perspective Airs Episode With the Founder of Traveler of Charleston Magazine 2Health News:USP Comments to WHO Regarding Biologics Qualifier Proposal 2
... ... for small groups and business insurance premiums. Now, they are getting some answers and are ... , ... 3, 2009 -- The health care reform bills in being considered by the House, which ...
... , CHICAGO, July 2 Recent news reports have ... physicians meet high standards in their chosen area of ... (ABMS), which coordinates and assists its 24 Member Boards ... professional standards for the evaluation and certification of physician ...
... Dr Daniel Goldberg, a leading New Jersey ophthalmologist is ... 5% Betadine irrigation for treatment of acute EKC -- a ... with the potential for long term visual impairment due to ... invited to register to participate in the Betadine for EKC ...
... can help reduce threat, expert says , THURSDAY, ... threat to certain species of wildlife, which need to ... is one of the leading health concerns for humans, ... But we now understand that cancer can kill wild ...
... hepatitis B virus (HBV) are associated with the development of ... infections are at increased risk of the disease, according to ... Cancer Institute , published online July 2. HBV infection ... common form of liver cancer. Previous studies have looked at ...
... 2 American Scientific Resources, Inc. (Pink Sheets: ASFX), ... McWilliams, will be dedicating herself full-time to the position ... for Next One Interactive. , , Ms. ... Chief Financial Officer. She possesses in-depth, practical knowledge ...
Cached Medicine News:Health News:Health Care Reform Details Emerge with 'Play or Pay' Requirements, Leaving Some Wondering about Small Business Owner Insurance 2Health News:Health Care Reform Details Emerge with 'Play or Pay' Requirements, Leaving Some Wondering about Small Business Owner Insurance 3Health News:Seek Out Credentials Before Choosing a Physician - Is Your Cardiologist Board Certified in Cardiovascular Disease? 2Health News:Seek Out Credentials Before Choosing a Physician - Is Your Cardiologist Board Certified in Cardiovascular Disease? 3Health News:Seek Out Credentials Before Choosing a Physician - Is Your Cardiologist Board Certified in Cardiovascular Disease? 4Health News:Ophthalmologists Invited To Participate in Betadine for EKC Treatment Study 2Health News:Cancer Endangers Some Wildlife Species 2Health News:American Scientific Resources Announces Acting CFO Transition to Full-Time 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: